Cristin Kaspar is a Nephrology physician affiliated with Alnylam Pharmaceuticals. OpenAlex indexes 17 publications with 275 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9000 W Wisconsin Ave
Milwaukee, WI 532264874
Telephone
414-337-7140Provider last certified this registry record 21 Dec 2022.
Clinical trials
- Sickle Cell Uric Acid (SCUA) - Cohort Repository
Sponsor: Virginia Commonwealth University
- Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
Sponsor: Virginia Commonwealth University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial
American Journal of Kidney Diseases
2025 - Final 60-Month Efficacy, Safety, and Kidney Stone Outcomes of a Phase 3 Trial of Lumasiran for Primary Hyperoxaluria Type 1 in Infants and Young Children
Journal of the American Society of Nephrology
2025 - Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1
Clinical Journal of the American Society of Nephrology
2025 - #2388 Long-term efficacy and safety in the 60-month, Phase 3 ILLUMINATE-B trial of lumasiran in infants and young children with primary hyperoxaluria type 1
Nephrology Dialysis Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sameer Bansilal, MD
Alnylam Pharmaceuticals
Ishir Bhan, MD
Alnylam Pharmaceuticals
Patrick Haslett, MD
Alnylam Pharmaceuticals
Olivier Huttin
Alnylam Pharmaceuticals
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”